The submission represents Gilead Sciences, a major S&P 500 biopharmaceutical company with a ~$150B market cap and 17,600+ employees. While the project is a global leader in life-saving therapeutics (HIV, Hepatitis, Oncology) justifying maximum scores for utility and traction, the specific submission quality is poor ('everyone' audience, hyperbolic claims). The score reflects the undeniable scale and impact of the entity, adjusted downward slightly for the low-effort input and lack of specific software innovation details.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline